Epilepsy control with carbamazepine monotherapy from a genetic perspective
Abstract Background Ethnicity variation is one of the main factors that may affect drug response in clinical practice. As MTHFR gene affects different transcriptome and proteome which affect the clinical response of drugs. Purpose of the current study was to observe possible variations in plasma lev...
Main Authors: | Shakir Ullah, Niaz Ali, Adnan Khan, Saad Ali, Haleema Rehna Nazish, Zia Uddin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40360-018-0261-y |
Similar Items
-
The Effect of Long-Term Carbamazepine Monotherapy on Serum Lipid Levels in Epilepsy Patients
by: İsmail Apak, et al.
Published: (2008-01-01) -
Development and validation of SPE-HPLC method for the determination of carbamazepine and its metabolites carbamazepine epoxide and carbamazepine trans-diol in plasma
by: Spasić Mirjana, et al.
Published: (2012-01-01) -
Cognitive and Behavioral Effects of Topiramate Versus Carbamazepine Monotherapy
by: J Gordon Millichap
Published: (2007-09-01) -
Restless Legs Syndrome Among the Epilepsy Patients who Took Carbamazepine or Valproic Acid Monotherapy
by: Mehtap KOCATÜRK, et al.
Published: (2013-01-01) -
Carbamazepine - Exacerbated Epilepsy
by: J Gordon Millichap
Published: (1987-06-01)